The Motley Fool

My top 3 FTSE 100 shares to buy in December

Image source: Getty Images

Three global companies are currently at the top of my list of FTSE 100 shares to buy in December. The Covid-19 pandemic has impacted their businesses to different degrees. However, all three are quality operators, and I reckon their discount prices make them very buyable for the long term.

This FTSE 100 share is dirt cheap

In its half-year results in July, British American Tobacco (LSE: BATS) reported: “The business is performing well in difficult circumstances.”

5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!

According to one leading industry firm, the 5G boom could create a global industry worth US$12.3 TRILLION out of thin air…

And if you click here we’ll show you something that could be key to unlocking 5G’s full potential...

Management said it expects constant currency adjusted revenue growth of 1-3% for the full year. This is below its medium-term 3-5% target. But that’s a highly creditable performance, given an estimated 3% headwind from Covid-19. Similarly, guidance for mid-single-digit growth in earnings is admirable, but lower than the post-Covid-19 target of high single digits.

The guidance puts BATS on a sub-10 price-to-earnings (P/E) ratio. And with the company committed to a 65% dividend pay-out ratio, the prospective yield is north of 7%.

I think the stock is cheap, and that management has a credible strategy for future growth. Its aim is to accelerate reduced-risk ‘new categories’ revenue at a faster rate than total revenue. Its recent acquisition of Dryft Modern Oral enhances its portfolio of new-category products, and will contribute to accelerated growth.

Healthcare also features among my shares to buy

In a third-quarter trading update last month, global medical technology group Smith & Nephew (LSE: SN) reported “a substantial improvement in performance over the previous quarter.”

Q3 underlying revenue was down 4.2% compared with a 29.3% slump in Q2. The improvement came as global levels of elective surgery recovered. Indeed, SN actually saw growth in its two largest markets, the US and China.

Despite the challenging year, the company has continued to invest in its medium-term ambitions. Namely, to consistently outgrow its markets and increase its trading profit margin. To this end, it’s continued with major new product launches, as well as making an acquisition that expands its portfolio in higher-growth extremity orthopaedics.

Analysts are forecasting a big increase in EPS next year, leading to a sub-20 P/E and 2% dividend yield. I think the valuation is attractive for a company with strong structural growth drivers in the shape of ageing populations and rising healthcare spend in developing economies.

A go-to FTSE 100 share I’d buy

Food and household goods favourite Unilever (LSE: ULVR) last month reported underlying sales growth of 4.4% in its third quarter. Management pointed to “the resilience of our portfolio and our agility in responding to rapidly changing dynamics across consumer segments, geographies and channels.”

Growth was particularly strong in home and hygiene, with germ-killing and antibacterial products seeing strong demand. Demonstrating the aforementioned agility, the company launched Domestos in China, as well as extending the brand to bleach-based spray and wipe formats.

The group owns a formidable array of much-loved names across its divisions. Personal care brand Dove, whose range has been extended into the antibacterial segment, and food favourite Hellmann’s are just two of 12 brands in its 400-strong portfolio that generate sales of over €1bn a year.

Based on current-year earnings and dividend forecasts, ULVR has a P/E of around 20, with a 3.2% yield. Global brands powerhouses are rare and valuable jewels, and I reckon the P/E and yield represent excellent value.

A Top Share with Enormous Growth Potential

Savvy investors like you won’t want to miss out on this timely opportunity…

Here’s your chance to discover exactly what has got our Motley Fool UK analyst all fired up about this ‘pure-play’ online business (yes, despite the pandemic!).

Not only does this company enjoy a dominant market-leading position…

But its capital-light, highly scalable business model has previously helped it deliver consistently high sales, astounding near-70% margins, and rising shareholder returns … in fact, in 2019 it returned a whopping £150m+ to shareholders in dividends and buybacks!

And here’s the really exciting part…

While COVID-19 may have thrown the company a curveball, management have acted swiftly to ensure this business is as well placed as it can be to ride out the current period of uncertainty… in fact, our analyst believes it should come roaring back to life, just as soon as normal economic activity resumes.

That’s why we think now could be the perfect time for you to start building your own stake in this exceptional business – especially given the shares look to be trading on a fairly undemanding valuation for the year to March 2021.

Click here to claim your copy of this special report now — and we’ll tell you the name of this Top Growth Share… free of charge!

G A Chester has no position in any of the shares mentioned. The Motley Fool UK has recommended Unilever. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

Our 6 'Best Buys Now' Shares

The renowned analyst team at The Motley Fool UK have named 6 shares that they believe UK investors should consider buying NOW.

So if you’re looking for more stock ideas to try and best position your portfolio today, then it might be a good day for you. Because we're offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our 'no quibbles' 30-day subscription fee refund guarantee.

Simply enter your email address below to discover how you can take advantage of this.

I would like to receive emails from you about product information and offers from The Fool and its business partners. Each of these emails will provide a link to unsubscribe from future emails. More information about how The Fool collects, stores, and handles personal data is available in its Privacy Statement.